Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
NPS 2143 results in a rapid 4- to 5-fold increase in plasma PTH levels and also a transient increase in plasma Ca2+ levels
selective and cell permeable BRPF1 bromodomain inhibitor with IC50 ~ 80 nM
Darbufelone
InChi: InChI=1S/C9H7Cl2N5
Tirzepatide TFA 15082 NPS 2143 results in aTirzepatide TFA (LY3298176 TFA) is a dual glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP 1) receptor agonist that is being developed for the treatment of type 2 diabetes. Product information Molecular Weight: 4927. 47 Formula: C227H349F3N48O70 Chemical Name: (2S) 2 [[20 [[(5S) 6 [[(2S, 3S) 1 [[(2S) 1 [[(2S) 5 amino 1 [[(2S) 6 amino 1 [[(2S) 1 [[(2S) 1 [[(2S) 1 [[(2S) 5 amino 1 [[(2S) 1 [[(2S) 1 [[(2S, 3S) 1 [[(2S)